Potential conflict of interest: Nothing to report.
Persistent viremia in human immunodeficiency virus/hepatitis B coinfected patients undergoing long-term tenofovir: Virological and clinical implications
Article first published online: 20 JUN 2014
© 2014 by the American Association for the Study of Liver Diseases
Volume 60, Issue 2, pages 497–507, August 2014
How to Cite
Boyd, A., Gozlan, J., Maylin, S., Delaugerre, C., Peytavin, G., Girard, P.-M., Zoulim, F. and Lacombe, K. (2014), Persistent viremia in human immunodeficiency virus/hepatitis B coinfected patients undergoing long-term tenofovir: Virological and clinical implications. Hepatology, 60: 497–507. doi: 10.1002/hep.27182
This study has been funded, in part, by Sidaction (AO 19) and received additional grants from ANRS (Agence Nationale de Recherche sur le Sida et les Hépatites). Gilead Sciences, Inc., provided an unrestricted grant for the French HIV-HBV cohort. Roche Diagnostics gave additional funding for antigen quantification. Both Gilead Sciences, Inc., and Roche Diagnostics were not involved in any part of the data collection, analysis, and manuscript writing. A.B. was awarded a postdoctoral fellowship from the ANRS.
- Issue published online: 22 JUL 2014
- Article first published online: 20 JUN 2014
- Accepted manuscript online: 19 APR 2014 12:19AM EST
- Manuscript Accepted: 15 APR 2014
- Manuscript Received: 11 FEB 2014
Additional Supporting Information may be found in the online version of this article at the publisher's website.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.